Literature DB >> 25919414

Factors Affecting the Enhancement Patterns of Intrahepatic Cholangiocarcinoma (ICC) on Contrast-Enhanced Ultrasound (CEUS) and their Pathological Correlations in Patients with a Single Lesion.

M X Yuan1, R Li1, X H Zhang1, C L Tang1, Y L Guo1, D Y Guo2, M K Luo3.   

Abstract

Purpose: To investigate the factors that influence the enhancement patterns of intrahepatic cholangiocarcinomas (ICC) on contrast-enhanced ultrasound (CEUS) and analyze the correlations between the enhancement patterns on CEUS and pathological findings. Materials and
Methods: Ninety-six patients with 96 pathologically confirmed ICCs underwent CEUS. CEUS images were retrospectively evaluated for tumor enhancement patterns in the arterial, portal and late phases. The arterial enhancement patterns were correlated with clinicopathological factors. The possible influencing factors were correlated with pathologic findings.
Results: Thirty-six patients with ICC demonstrated rim-like enhancement, and 60 exhibited non-rim-like enhancement in the arterial phase on CEUS. The incidence of non-rim-like-enhancing ICCs was higher in patients with cirrhosis and chronic viral hepatitis than patients with no chronic liver disease (p = 0.001). The sizes of the ICCs with homogeneous hyper-enhancement were significantly smaller than those with inhomogeneous hyper-enhancement (p = 0.007). Arterial non-rim-like-enhancing ICCs showed higher microvessel density (MVD) and arterial density (AD) and less fibrous stroma and necrosis than rim-like-enhancing ICCs. Arterial inhomogeneous-enhancing ICCs had lower MVD and AD and much more fibrous stroma and necrosis than homogeneous-enhancing ICCs.
Conclusion: The enhancement pattern of ICCs in the arterial phase on CEUS was affected by a liver cirrhosis and chronic viral hepatitis and tumor size. The amount of MVD, AD, fibrous stroma and necrosis in ICC tumors may be responsible for the difference in the enhancement patterns. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25919414     DOI: 10.1055/s-0034-1399485

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  9 in total

1.  Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.

Authors:  Fei Li; Qing Li; Yubo Liu; Jing Han; Wei Zheng; Yini Huang; Xueyi Zheng; Longhui Cao; Jian-Hua Zhou
Journal:  Eur Radiol       Date:  2019-07-11       Impact factor: 5.315

Review 2.  Imaging Diagnosis of Hepatocellular Carcinoma: Recent Advances of Contrast-Enhanced Ultrasonography with SonoVue®.

Authors:  Veronica Salvatore; Alice Gianstefani; Giulia Negrini; Giulia Allegretti; Marzia Galassi; Fabio Piscaglia
Journal:  Liver Cancer       Date:  2015-12-18       Impact factor: 11.740

3.  The diagnostic value of contrast-enhanced ultrasound LI-RADS for hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis B.

Authors:  Dan Yang; Hong Hu; Rui Li; Chun-Lin Tang; Kuan-Sheng Ma; De-Yu Guo
Journal:  Abdom Radiol (NY)       Date:  2021-12-15

4.  CT/MRI LI-RADS version 2018 versus CEUS LI-RADS version 2017 in the diagnosis of primary hepatic nodules in patients with high-risk hepatocellular carcinoma.

Authors:  Kun Lv; Xin Cao; Yinlei Dong; Daoying Geng; Jun Zhang
Journal:  Ann Transl Med       Date:  2021-07

Review 5.  Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system.

Authors:  Tae Kyoung Kim; Seung Yeon Noh; Stephanie R Wilson; Yuko Kono; Fabio Piscaglia; Hyun-Jung Jang; Andrej Lyshchik; Christoph F Dietrich; Juergen K Willmann; Alexander Vezeridis; Claude B Sirlin
Journal:  Clin Mol Hepatol       Date:  2017-09-15

6.  Contrast-enhanced ultrasound approach to the diagnosis of focal liver lesions: the importance of washout.

Authors:  Hyun Kyung Yang; Peter N Burns; Hyun-Jung Jang; Yuko Kono; Korosh Khalili; Stephanie R Wilson; Tae Kyoung Kim
Journal:  Ultrasonography       Date:  2019-03-17

7.  Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS.

Authors:  Yi-Xin Hu; Jing-Xian Shen; Jing Han; Si-Yue Mao; Ru-Shuang Mao; Qing Li; Fei Li; Zhi-Xing Guo; Jian-Hua Zhou
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

8.  Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?

Authors:  Jia-Yan Huang; Jia-Wu Li; Wen-Wu Ling; Tao Li; Yan Luo; Ji-Bin Liu; Qiang Lu
Journal:  World J Gastroenterol       Date:  2020-07-21       Impact factor: 5.742

9.  Establishment and evaluation of a Beagle model of grade III pancreatic trauma.

Authors:  Hanjing Gao; Qing Song; Faqin Lv; Bin Shi; Pengfei Wang; Yiru Wang; Yan Zhang; Li Yang; Yukun Luo; Xingguo Mei; Jie Tang
Journal:  Exp Ther Med       Date:  2018-08-24       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.